Warning: This data is provided for information purpose only. You should not start or stop any medication without consulting your care giver.
Use the Health Monitor application at http://www.healthsupportsystems.com to search for a drug by brand, generic or symptom
AGENERASE
Active Ingredients
AMPRENAVIR
Inctive Ingredients
acesulfame potassium,citric acid anhydrous,d-alpha tocopheryl polyethylene glycol 1000 succinate (TPGS),polyethylene glycol 400,propylene glycol,saccharin sodium,sodium chloride,sodium citrate dihydrate,sodium hydroxide,hydrochloric acid,artificial grape bubblegum flavor,menthol,natural peppermint flavor
Usage
AGENERASE (amprenavir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
The following points should be considered when initiating therapy with AGENERASE:
In a study of NRTI-experienced, protease inhibitor-naive patients, AGENERASE was found to be significantly less effective than indinavir (see Description of Clinical Studies).
Mild to moderate gastrointestinal adverse events led to discontinuation of AGENERASE primarily during the first 12 weeks of therapy (see ADVERSE REACTIONS).
There are no data on response to therapy with AGENERASE in protease inhibitor-experienced patients.
AGENERASE Oral Solution should be used only when AGENERASE Capsules or other protease inhibitor formulations are not therapeutic options.